Compounded Acetyl-L-Cysteine Eye Drops Recalled for Lack of Processing Controls
Compounded Solutions in Pharmacy is recalling 10% Acetyl-L-Cysteine Ophthalmic Solutions due to a lack of processing controls.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the source text does not report any illnesses or injuries, fitting the criteria for a moderate severity score.
Plain-English summary
Compounded Solutions in Pharmacy is recalling 10% Acetyl-L-Cysteine Ophthalmic Solutions, which are dispensed in 5ml, 10ml, and 15ml dropper bottles. The recall is being conducted because of a lack of processing controls.
The affected product was dispensed to patients. Specific lot numbers and expiration dates are listed in the official recall documentation.
Patients who have received this product should contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- 10% Acetyl-L-Cysteine Ophthalmic Solutions, dispensed in a) 5ml, b) 10ml c) 15 ml, dropper bottles
- Manufacturer
- Compounded Solutions in Pharmacy
- Category
- Drug — Ophthalmic
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (9)
- Lots: a) 08012019@33 exp: 8/15/19
- 07182019@66 exp: 8/01/19
- 07182019@15 exp: 8/01/19
- 07012019@46 exp. 08/31/19
- 07082019@27 exp: 8/31/19
- b) 07082019@55 exp: 8/31/19
- 07182019@55 exp: 08/31/19
- 06242019@55 exp: 8/31/19
- 06202019@16 exp: 8/31/19 c) 08052019@11 exp: 11/3/19
Distribution
Distribution scope not specified by the agency.
Part of a larger recall action
This product is one of 3 recalled by Compounded Solutions in Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · Compounded Solutions in Pharmacy
See all →- HighFDA Recalls Compounded Acetyl-L-Cysteine Ophthalmic Solution Due to Processing Controls
FDA (Drugs) · 2019-09-18
- ModerateCompounded Acetyl-L-Cysteine Eye Drops Recalled for Processing Control Issues
FDA (Drugs) · 2019-09-18
Same hazard · lack of processing controls
See all →- ModerateMasterPharm Recalls Vardenafil Troches Due to Lack of Processing Controls
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Progesterone Capsules Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Progesterone Troches Due to Lack of Processing Controls
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Yohimbine HCL Capsules Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
- ModerateMasterPharm Recalls Calcium Citrate Powder Due to Processing Control Deficiencies
FDA (Drugs) · 2020-08-05
Similar recalls
- ModerateRedline Pharmacy Recalls Acetylcysteine Ophthalmic Solution Due to Processing Controls
FDA (Drugs) · 2020-03-18
- SevereUS Compounding Recalls Acetylcysteine 10% Ophthalmic Solution for Sterility Concerns
FDA (Drugs) · 2015-11-25
- Severe
- SevereAcetylcysteine Eye Drops Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2019-04-24
- HighAcetylcysteine eye drops recalled for sterility assurance defect
FDA (Drugs) · 2022-11-09
- HighAcetylcysteine Eye Drops Recalled for Sterility Assurance Issues
FDA (Drugs) · 2022-11-09